Document Preview Unavailable
First‐in‐human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor
Shimizu, Hidetoshi; Tortorici, Michael A; Ohta, Yoshiyasu; Ogawa, Kei; Rahman, Sheikh Mohammed Ashfaq; et al. Clinical and Translational Science Vol. 17, Iss. 8, (Aug 1, 2024).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library